Patents by Inventor Barry Hurlburt

Barry Hurlburt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
    Patent number: 7018834
    Abstract: The present invention provides new site-specific HSV-thymidine kinase mutants with improved nucleoside analog metabolizing activity due to low or no thymidine phosphorylation ability. Also provided is a method of killing target cells using such mutants combined with a prodrug.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: March 28, 2006
    Assignee: The Board of Trustees of the University of Arkansas
    Inventors: Richard Drake, Trenton Hinds, Cesar Compadre, Barry Hurlburt, Tammy Rechtin
  • Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
    Publication number: 20030202964
    Abstract: The present invention provides new site-specific HSV-thymidine kinase mutants with improved nucleoside analog metabolizing activity due to low or no thymidine phosphorylation ability. Also provided is a method of killing target cells using such mutants combined with a prodrug.
    Type: Application
    Filed: June 9, 2003
    Publication date: October 30, 2003
    Applicant: Board of Trustees of the University of Arkansas
    Inventors: Cesar Compadre, Richard Drake, Trenton Hinds, Barry Hurlburt, Tammy Rechtin
  • Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
    Patent number: 6610289
    Abstract: The present invention provides new site-specific HSV-thymidine kinase mutants with improved nucleoside analog metabolizing activity due to low or no thymidine phosphorylation ability. Also provided is a method of killing target cells using such mutants combined with a prodrug.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: August 26, 2003
    Assignee: The Board of Trustees of the University of Arkansas
    Inventors: Richard Drake, Trenton Hinds, Cesar Compadre, Barry Hurlburt, Tammy Rechtin
  • Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
    Publication number: 20020146796
    Abstract: The present invention provides new site-specific HSV-thymidine kinase mutants with improved nucleoside analog metabolizing activity due to low or no thymidine phosphorylation ability. Also provided is a method of killing target cells using such mutants combined with a prodrug.
    Type: Application
    Filed: June 8, 2001
    Publication date: October 10, 2002
    Inventors: Richard Drake, Trenton Hinds, Cesar Compadre, Barry Hurlburt, Tammy Rechtin
  • Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
    Patent number: 6245543
    Abstract: The present invention provides new site-specific HSV-thymidine kinase mutants with improved nucleoside analog metabolizing activity due to low or no thymidine phosphorylation ability. Also provided is a method of killing target cells using such mutants combined with a prodrug.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: June 12, 2001
    Inventors: Richard Drake, Trenton Hinds, Cesar Compadre, Barry Hurlburt, Tammy Rechtin